6.1 Apheresis Flashcards

1
Q

Collection of a specific blood component while returning the remaining whole blood components back to the patient

A

Apheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In apheresis, the remaining whole blood that returns to the patient is based on Differences in?

A

Density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Advantages in Apheresis:

Small Volume of blood

Removal of unwanted substance

T or F

A

F

Large volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anticoagulant for apheresis

A

Citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Methods of centrifugation:

One puncture site for blood to be collected

a. Intermittent Flow Centrifugation
b. Continuous Flow Centrifugation

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Methods of centrifugation:

Blood is processed in batches or cycles

a. Intermittent Flow Centrifugation
b. Continuous Flow Centrifugation

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methods of centrifugation:

2 Punture Cite (1 for blood collection, 1 for returning of blood components)

a. Intermittent Flow Centrifugation (IFC)
b. Continuous Flow Centrifugation (CFC)

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Methods of centrifugation:

Blood withdrawal, processing, reinfusion are performed simultaneously in a on going manner

a. Intermittent Flow Centrifugation (IFC)
b. Continuous Flow Centrifugation (CFC)

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Methods of centrifugation:

Which is one is faster?

a. Intermittent Flow Centrifugation (IFC)
b. Continuous Flow Centrifugation (CFC)

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type of apheresis

Plasma

A

Plasmapheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type of apheresis

Platelet

A

Plateletpheresis (Single donor platelet concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type of apheresis

Leukocytes

A

Leukapheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Type of apheresis

RBC

A

Erythrocythapheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Type of apheresis

Hematopoietic progenitor cells

A

HPC apheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In Leukapheresis:

Sedimenting agent

a. Hydroxyethyl starch
b. Corticosteroids
c. Growth Factors

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In Leukapheresis:

Increases Leukocytes harvest

a. Hydroxyethyl starch
b. Corticosteroids
c. Growth Factors

A

b and c

17
Q

In Leukapheresis:

Separated WBC from other cell

a. Hydroxyethyl starch
b. Corticosteroids
c. Growth Factors

A

a

18
Q

In Leukapheresis:

Prednisone or dexamethaone

a. Hydroxyethyl starch
b. Corticosteroids
c. Growth Factors

A

b

19
Q

Process of collecting 2 units of red cell

A

Double RBC Pheresis

20
Q

What do you call apheresis for platelets?

A

Single donor concentrate

21
Q

What do you call platelet coming from Whole blood collection?

A

Random donor platelets

22
Q

How many random donor platelets for Plateletpheresis

A

6-8

23
Q

FDA Guidelines for 2RBC

Male:

_____lbs, minimum height _____

A

130, 5’1

24
Q

FDA Guidelines for 2RBC

Female:

_____lbs, minimum height _____

A

150, 5’5

25
Q

FDA Guidelines for 2RBC

Hematocrit?

A

40%

26
Q

In plasmapheresis:

No more than one procedure in a 4 week period

a. Infrequent donor
b. Serial donor

A

a

27
Q

In plasmapheresis:

Donate more frequently than 4 weeks

a. Infrequent donor
b. Serial donor

A

b

28
Q

A Pathologenic substance exists in the blood that contributes to a disease process or its symptoms

A

Therapeutic cytapheresis

29
Q

Indication categories for therapeutic Apheresis:

Apheresis is standard and acceptable, either as primary therapy or as a first line adjunt to other initial therapies

A

I

30
Q

Indication categories for therapeutic Apheresis:

Apheresis has been demonstrated to lack efficacy or be harmful and should be discouraged in these disorders

A

IV

31
Q

Indication categories for therapeutic Apheresis:

Apheresis is not clearly indicated based on insufficient evidence, conflicting results, or inability to document a favorable risk-to-benefit ratio

A

III

32
Q

Indication categories for therapeutic Apheresis:

Apheresis is generally accepted in a supportive role or as second-line therapy, rather than first-line therapy

A

II